DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Everolimus, Atc L04aa18 for the Period February 1St, 2024 - January 31St, 2.... The project location is Germany and the tender is closing on 05 Dec 2025. The tender notice number is -, while the TOT Ref Number is 93903555.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Everolimus, Atc L04aa18 for the Period February 1St, 2024 - January 31St, 2...
Sign in with Google